While reading this article, noticed the following:
Post# of 30028
Quote:
We believe the timing of this article is ideal, as our emerging diagnostics division, Amarantus Diagnostics, is ready to have a major impact in the field of biomarkers to diagnose Alzheimer’s disease, and potentially monitor drug response.
Is Lympro being targeted as a tool for monitoring drug response?